BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18307725)

  • 1. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
    Jeske YW; So A; Kelemen L; Sukor N; Willys C; Bulmer B; Gordon RD; Duffy D; Stowasser M
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):380-5. PubMed ID: 18307725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred.
    Elphinstone MS; Gordon RD; So A; Jeske YW; Stratakis CA; Stowasser M
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):716-23. PubMed ID: 15579186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.
    So A; Duffy DL; Gordon RD; Jeske YW; Lin-Su K; New MI; Stowasser M
    J Hypertens; 2005 Aug; 23(8):1477-84. PubMed ID: 16003173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II.
    Carss KJ; Stowasser M; Gordon RD; O'Shaughnessy KM
    J Hum Hypertens; 2011 Sep; 25(9):560-4. PubMed ID: 20927129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.
    Sukor N; Mulatero P; Gordon RD; So A; Duffy D; Bertello C; Kelemen L; Jeske Y; Veglio F; Stowasser M
    J Hypertens; 2008 Aug; 26(8):1577-82. PubMed ID: 18622235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
    Lafferty AR; Torpy DJ; Stowasser M; Taymans SE; Lin JP; Huggard P; Gordon RD; Stratakis CA
    J Med Genet; 2000 Nov; 37(11):831-5. PubMed ID: 11073536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
    Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
    Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
    Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7.
    Osborne LR; Herbrick JA; Greavette T; Heng HH; Tsui LC; Scherer SW
    Genomics; 1997 Oct; 45(2):402-6. PubMed ID: 9344666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II.
    So A; Jeske YW; Gordon RD; Duffy D; Kelemen L; Stowasser M
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):829-31. PubMed ID: 17121540
    [No Abstract]   [Full Text] [Related]  

  • 13. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in a pseudogene highly homologous to PMS2.
    Chadwick RB; Meek JE; Prior TW; Peltomaki P; de La Chapelle A
    Hum Mutat; 2000 Dec; 16(6):530. PubMed ID: 11102987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
    Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
    Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMS2 mutations in childhood cancer.
    De Vos M; Hayward BE; Charlton R; Taylor GR; Glaser AW; Picton S; Cole TR; Maher ER; McKeown CM; Mann JR; Yates JR; Baralle D; Rankin J; Bonthron DT; Sheridan E
    J Natl Cancer Inst; 2006 Mar; 98(5):358-61. PubMed ID: 16507833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
    Auclair J; Leroux D; Desseigne F; Lasset C; Saurin JC; Joly MO; Pinson S; Xu XL; Montmain G; Ruano E; Navarro C; Puisieux A; Wang Q
    Hum Mutat; 2007 Nov; 28(11):1084-90. PubMed ID: 17557300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.